Aileron Therapeutics (ALRN) Q2 2024 Earnings

15MayConfirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
-1.02
-0.73
-0.43
-0.14

Details

Expected EPS
-0.14
Actual EPS
-0.86
Surprise EPS
-0.72
Surprise Percent
+514.29%

Description

Aileron Therapeutics (ALRN) has reported earnings of -0.86 per share for Q2 2024.

0 Comments

Share your thoughts